ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Mar 31, 2023 19:39 JST
Source:
Huatai Securities Co., Ltd.
HTSC announces 2022 annual results, Proposes final dividend of RMB 0.45 per share
HONG KONG, Mar 31, 2023 - (ACN Newswire) - HTSC (stock code: 6886.HK ; "the Company"), a leading global financial services provider, is pleased to announce the Company's annual results for the year ended December 31, 2022.
-- Revenue for the year was RMB 46.82 billion
-- Profit attributable to shareholders amounted to RMB 11.05 billion
-- Total equity attributable to shareholders of the Company grew 11.23% year-on-year to RMB 165.09 billion.
-- The Company proposed a final dividend of RMB 0.45 per share
The wealth management business reported a revenue of RMB 23.48 billion and continued to account for the majority of the Company's total revenue of 50.15%. Revenues from the institutional services business and investment management business were RMB 8.13 billion and RMB 2.27 billion, accounting for 17.37% and 4.85%, respectively, of the Company's total.
The international business segment posted a record revenue of RMB 9.41 billion despite global economic challenges, growing by 19.28% year-on-year and accounting for 20.10% of the Company's total. During the year, the Company was ranked second as a sponsor amongst Chinese securities companies in Hong Kong by amount.
HTSC's US subsidiary AssetMark - a leading US turnkey asset management platform (TAMP), with total assets under management of USD 91.47 billion as of December 31, 2022, continued to provide a stable stream of revenue for the Company's international business. As of the end of the third quarter 2022, AssetMark's market share in the US TAMP industry was 11.2%, ranking third in the industry. In addition, Huatai International applied to establish a wholly-owned subsidiary in Singapore and received a "no-objection" letter from the China Securities Regulatory Commission (CSRC) in September 2022.
The trading volume of stocks and funds in 2022 amounted to RMB 38.76 trillion, as the Company retained the top spot in the industry. Equity and mixed mutual funds and non-money-market mutual funds sold by HTSC amounted to RMB 122.6 billion and RMB 136.7 billion, respectively, both ranking second in the securities industry. HTSC's fund advisory service platform had approximately 617,600 users, with the size of authorized assets reaching RMB 13.91 billion. As of the end of 2022, the balance of the margin financing and securities lending business was RMB 112.35 billion, maintaining a market share of 7.29%. "ZhangLe Wealth", HTSC's wealth management app, remained the top brokerage app in China with 9.27 million monthly active users in average.
In 2022, the Company completed 81 equity underwriting deals, with principal underwriting for equities amounting to RMB 155.37 billion, ranking fourth in the industry for both the number and volume of transactions. Principal underwriting for bonds amounted to RMB 980.40 billion, as the Company retained the third rank in the industry. The Company advised on nine M&A and restructuring projects that were approved by the CSRC, with a total transaction volume of RMB 165.07 billion, ranking second in the industry for both the number of approved transactions and total transaction volume.
The Company continued to advance its ESG initiatives, taking into consideration the needs of all stakeholders within HTSC's ecosystem. Last year, the Company received an A rating for ESG from MSCI for the second year in a row, ranking top among Chinese securities companies. In March 2022, the Company, through Huatai Foundation, launched two philanthropic funds totaling RMB 30 million to support rural revitalization and environmental conservation projects, making positive social impact by giving back to the community and promoting sustainable development.
For enquiries, please contact:
Citigate Dewe Rogerson
Benny Liu
Tel: +86 10 6567 5056
Linda Pui
Tel: +852 3103 0118
Email:
HTSC@citigatedewerogerson.com
Source: Huatai Securities Co., Ltd.
Sectors: Daily Finance
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Victory and world title for TOYOTA GAZOO Racing
Nov 05, 2024 17:59 JST
Tokyo Stock Exchange and Fujitsu announce renewal of cash equity trading system 'arrowhead4.0'
Nov 05, 2024 17:13 JST
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
Nov 05, 2024 14:37 JST
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
Nov 05, 2024 11:35 JST
Asahi Kasei and Honda Sign Shareholders' Agreement to Convert Existing Asahi Kasei Subsidiary into Joint Venture for Production of Lithium-ion Battery Separators in Canada
Nov 04, 2024 14:12 JST
Joby Aviation and Toyota Accelerate Efforts to Realize Air Mobility
Nov 04, 2024 09:36 JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
Nov 01, 2024 13:56 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Nov 01, 2024 12:43 JST
Fujitsu's groundbreaking computing technology for accelerating scientific computing wins Japan Patent Office Commissioner's Award
Nov 01, 2024 12:24 JST
Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
Nov 01, 2024 10:45 JST
Mazda Launches Redesigned Corporate Website
Oct 31, 2024 17:06 JST
NTT and Toyota Motor Corporation agree to joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents
Oct 31, 2024 16:34 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Oct 31, 2024 16:08 JST
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference
Oct 31, 2024 13:56 JST
Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
Oct 31, 2024 11:33 JST
Mazda Production and Sales Results for September 2024 and for April through September 2024
Oct 30, 2024 17:09 JST
Suzuki and Toyota to Deepen Collaboration in the Field of Electrified Vehicles
Oct 30, 2024 16:14 JST
Fujitsu and Morinaga Milk Industry jointly develop a simulation system for raw material price fluctuations, speeding up decision-making
Oct 30, 2024 13:43 JST
DOCOMO to Participate in Virtual Expo at Expo 2025 Osaka, Kansai, Japan
Oct 30, 2024 12:47 JST
ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea
Oct 30, 2024 11:00 JST
More Latest Release >>
Related Release
Huatai Securities Co-Launches China's First OECMs Fund to Support the UN's 30x30 Biodiversity Target
October 29 2024 19:38 JST
Huatai Securities Backs Collection of Potential OECM Cases in China
August 09 2024 19:29 JST
Huatai Securities Becomes First Securities Company in Mainland China to Achieve AA MSCI ESG Rating, Ascending to Global Leadership
December 01 2023 13:26 JST
HTSC reports annual revenue of RMB 46.82 billion in 2022
March 31 2023 18:35 JST
Huatai Securities Attends the 14th Meeting of the Conference of the Contracting Parties to the Ramsar Convention on Wetlands (COP14)
November 09 2022 09:47 JST
HKTDC and Huatai International launch strategic partnership
August 16 2022 18:00 JST
HTSC posts highest-ever annual revenue and profit
March 31 2022 09:52 JST
Huatai Securities' Ecological Conservation Project Shines in CBD COP15's Call to Action
September 28 2021 09:39 JST
Yang Xiaosong: The Institutional Investors Road to Carbon Neutrality
August 31 2021 11:00 JST
KPMG report highlights fintech and digitalisation as growth drivers of Mainland China's securities industry
August 30 2021 13:20 JST
More Press release >>